Literature DB >> 20517697

Impact of moderate exercise workload on predicted optimal AV and VV delays determined by an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Margit Strauss1, Torsten Becker, Thomas Kleemann, Ngoc Dyck, Frank Birkenhauer, Karlheinz Seidl.   

Abstract

AIMS: Aim of this study is to evaluate reproducibility, consistency and the impact of moderate exercise workload on optimized PV and VV delays as determined by the IEGM-based QuickOpt™ method (St. Jude Medical), that was shown to produce hemodynamic performance similar to that obtained by echo-guided aortic VTI maximization.
METHODS: Sixty patients with CRT-ICD (65 ± 9 years, 12% female, LVEF 28 ± 9%, 48% CAD and 52% DCM) were enrolled. IEGM-based PV/VV optimization was conducted six times: twice at rest, twice immediately after a 6-min walk test and twice following a 3-min recovery period. Timing cycle delays were programmed in accordance with the optimization results. Follow-up was performed after 1 year.
RESULTS: Although significant difference in heart rate was reached [68 ± 9 bpm (REST) vs. 79 ± 12 (6MWT), p < 0.001], differences were not observed between IEGM-based optimized PV/VV delays: PV(opt) = 128 ± 14 ms (REST) versus 130 ± 17 ms (6MWT) versus 129 ± 16 ms (RECOV); VV(opt) = 15 ± 24 ms (REST) versus 15 ± 22 ms (6MWT) versus 16 ± 24 ms (RECOV). During 1-year follow-up PV(opt) and VV(opt) remained stable (ΔPV(opt) = 10 ± 10 ms, ΔVV(opt) = 9 ± 11 ms).
CONCLUSION: Optimized IEGM-based timing cycle delays are independent of moderate exercise status within a particular patient but varied between patients. This supports the use of PV/VV optimization in each CRT patient.

Entities:  

Mesh:

Year:  2010        PMID: 20517697     DOI: 10.1007/s00392-010-0178-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  18 in total

1.  Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure.

Authors:  Zachary I Whinnett; Justin E R Davies; Keith Willson; Anthony W Chow; Rodney A Foale; D Wyn Davies; Alun D Hughes; Darrel P Francis; Jamil Mayet
Journal:  Europace       Date:  2006-05       Impact factor: 5.214

2.  Should we use the rate-adaptive AV delay in cardiac resynchronization therapy-pacing?

Authors:  Christoph Melzer; Hansjürgen Bondke; Thomas Körber; Christoph A Nienaber; Gert Baumann; Bruno Ismer
Journal:  Europace       Date:  2007-11-23       Impact factor: 5.214

3.  Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing.

Authors:  Pierre Bordachar; Stephane Lafitte; Sylvain Reuter; Prashanthan Sanders; Pierre Jaïs; Michel Haïssaguerre; Raymond Roudaut; Stephane Garrigue; Jacques Clementy
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

4.  Estimation of the optimal VV delay by an IEGM-based method in cardiac resynchronization therapy.

Authors:  Xiaoyi Min; Mathias Meine; James H Baker; Luis A Pires; Kyong T Turk; Evelyn M Horn; Robert C Kowal; Michael Paris; Euljoon Park; Eric S Fain
Journal:  Pacing Clin Electrophysiol       Date:  2007-01       Impact factor: 1.976

5.  Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy.

Authors:  Jeffrey E Kerlan; Navinder S Sawhney; Alan D Waggoner; Mohit K Chawla; Sanjeev Garhwal; Judy L Osborn; Mitchell N Faddis
Journal:  Heart Rhythm       Date:  2006-02       Impact factor: 6.343

6.  Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy.

Authors:  Navinder S Sawhney; Alan D Waggoner; Sanjeev Garhwal; Mohit K Chawla; Judy Osborn; Mitchell N Faddis
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

7.  Atrioventricular interval optimization and exercise tolerance.

Authors:  P Khairy; M Talajic; M Dominguez; J C Tardif; M Juneau; L Lavoie; D Roy; M Dubuc
Journal:  Pacing Clin Electrophysiol       Date:  2001-10       Impact factor: 1.976

8.  Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up.

Authors:  Cinzia Valzania; Mauro Biffi; Cristian Martignani; Igor Diemberger; Matteo Bertini; Matteo Ziacchi; Letizia Bacchi; Guido Rocchi; Claudio Rapezzi; Angelo Branzi; Giuseppe Boriani
Journal:  Echocardiography       Date:  2007-10       Impact factor: 1.724

9.  The atrioventricular delay of cardiac resynchronization can be optimized hemodynamically during exercise and predicted from resting measurements.

Authors:  Zachary I Whinnett; Cathy Briscoe; Justin E R Davies; Keith Willson; Charlotte H Manisty; D Wyn Davies; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Darrel P Francis
Journal:  Heart Rhythm       Date:  2007-12-04       Impact factor: 6.343

10.  A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Authors:  Maria Cristina Porciani; Carmelo Massimiliano Rao; Matteo Mochi; Francesco Cappelli; Gabriella Bongiorno; Alessandro Paoletti Perini; Alessio Lilli; Giuseppe Ricciardi; Lawrence Hashtroudi; Paolo Silvestri; S Serge Barold; Luigi Padeletti
Journal:  Pacing Clin Electrophysiol       Date:  2008-01       Impact factor: 1.976

View more
  2 in total

1.  AV interval optimization using pressure volume loops in dual chamber pacemaker patients with maintained systolic left ventricular function.

Authors:  Frank Eberhardt; Thorsten Hanke; Joern Fitschen; Matthias Heringlake; Frank Bode; Heribert Schunkert; Uwe K H Wiegand
Journal:  Clin Res Cardiol       Date:  2012-03-09       Impact factor: 5.460

2.  Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronization.

Authors:  Ji Yan; Shu Zhang; Dejia Huang; Xiaolin Xue; Jing Xu; Qianmin Tao; Weize Zhang; Zheng Zhang; Wei Hua; Yanchun Liang; Baopeng Tang; Wei Xu; Geng Xu; Xuejun Ren; Jingfeng Wang; Tao Guo; Shaobin Jia; Yugang Dong; Hong Jiang; Guosheng Fu; Liguang Zhu; Lin Chen; Fuli Tian; Feng Ling; Jianmei Li; Xiaoyong Qi; Yinglu Hao; Yutang Wang; Liangrong Zheng; Xiaoqun Pu; Farong Shen; Guangping Li; Hui Li; Fang Peng
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.